covid
Buscar en
Revista Colombiana de Anestesiología
Toda la web
Inicio Revista Colombiana de Anestesiología Síndrome hepatopulmonar y trasplante hepático
Journal Information
Vol. 36. Issue 4.
Pages 293-296 (November - January 2009)
Share
Share
Download PDF
More article options
Vol. 36. Issue 4.
Pages 293-296 (November - January 2009)
Reporte de Casos
Open Access
Síndrome hepatopulmonar y trasplante hepático
Visits
2454
Luis Fernando Gonzalez**, Douglas Leal*, Carlos Andrés Vidal**, Diego Zuluaga**, Fredy Ariza**, Carolina Giraldo+
* Residente III año de Anestesiología. Universidad Industrial de Santander. Hospital Universitario de Santander
** Anestesiólogo Institucional Grupo de Trasplante Hepático Fundación Valle de Lili.
+ Residente III año de Anestesiología. Universidad del Valle.
This item has received

Under a Creative Commons license
Article information
RESUMEN

El síndrome hepatopulmonar es una entidad clínica que compromete severamente el estado funcional de los pacientes con enfermedad hepática en estado terminal No se puede predecir con exactitud la historia natural de este síndrome una vez ha sido diagnosticado. Sin embargo se reconoce que su pronóstico es grave, lentamente progresivo y aunque la causa de muerte suele estar relacionada a la enfermedad hepática, la calidad de vida de estos pacientes se ve notablemente alterada por el trastornoventilatorio asociado. Se considera que el trasplante hepático, en casos bien seleccionados, puede lograr la completa resolución de este síndrome y el éxito en el manejo perioperatorioestá directamente relacionado con el conocimiento de la fisiopatología.

Palabras clave:
Anestesia
trasplante hepático ortotópico
síndrome hepatopulmonar
Key words:
anesthesia
orthoptic hepatic transplantation
hepatopulmonary syndrome
SUMMARY

Hepatopulmonary syndrome is a clinical entity that severely impairs functional status of patients with end stage liver disease. Natural course of this syndrome is unpredictable once it has been diagnosed. However it is known that its prognosis is serious, slowly progressive and although cause of death is often related to liver disease, quality of life in these patients is significantly impaired by the additional ventilatory disorder. It is actually considered that liver transplantation, in selected cases, can lead to complete resolution of this syndrome and so success in the perioperative management is directly related to the knowledge of the pathophysiology process.

Full text is only aviable in PDF
BIBLIOGRAFÍA
[1.]
T.C. Kennedy, R.J. Knudson.
Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis.
Chest, 72 (1977), pp. 305-309
[2.]
M. Krowka.
Hepatopulmonary syndromes. Gut, 46 (2000), pp. 1-4
[3.]
R. Rodríguez-Roisin, M. Krowka, P. Hervé, M. Fallon.
Highlights of the ERS Task Force on pulmonaryhepatic vascular disorders (PHD).
J Hepatology, 42 (2005), pp. 924-927
[4.]
M. Krowka.
Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation.
Clinics in Chest Medicine, 26 (2005), pp. 587-597
[5.]
M. Fallon.
Mechanisms of Pulmonary Vascular Complications of Liver Disease Hepatopulmonary Syndrome.
J Clin Gastroenterol, 39 (2005), pp. S138-S142
[6.]
G. Rolla.
Hepatopulmonary syndrome: role of nitric oxide and clinical aspects.
Dig Liver Dis, 36 (2004), pp. 303-308
[7.]
P. Schenk, V. Fuhrmann, C. Madl.
Hepatopulmonary syndrome: prevalence and predictive value of various cut off for arterial oxygenation and their clinical consequences.
Gut, 51 (2002), pp. 853-859
[8.]
M. Arguedas, B. Drake, A. Kapoor, M. Fallon.
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.
Gastroenterology, 128 (2005), pp. 328-333
[9.]
M. Hoeper, M. Krowka, C. Strassburg.
Portopulmonary hypertension and hepatopulmonary syndrome.
Lancet, 363 (2004), pp. 1461-1468
[10.]
S. Muñoz.
Síndrome hepatopulmonar e hipertensión portopulmonar.
Definiciones y terapias. Gastr Latinoam, 17 (2006), pp. 222-235
[11.]
A.T. Mazzeo, T. Lucanto, L.B. Santamaría.
Hepatopulmonary syndrome: a concern for the anesthetist? Preoperative evaluation of hypoxemic patients with liver disease.
Acta Anaesthesiol Scand, 48 (2004), pp. 178-186
[12.]
M.J. Krowka, M.S. Mandell, M.A. Ramsay.
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
Liver Transpl, 10 (2004), pp. 174-178
[13.]
K.L. Swanson, R.H. Wiesner, M.J. Krowka.
Natural history of hepatopulmonary syndrome: impact of liver transplantation.
Hepatology, 41 (2005), pp. 1122-1129
[14.]
M.R. Arguedas, G.A. Abrams, M.J. Krowka, M.B. Fallon.
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.
Hepatology, 37 (2003), pp. 192-197
[15.]
M.B. Fallon, D.C. Mulligan, R.G. Gisch, M.J. Krowka.
Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
Liver Transpl, 12 (2006), pp. s105-s107
[16.]
H.M. Lasch, M.W. Fried, S.L. Zacks.
Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome.
Liver Transpl, 7 (2001), pp. 147-149
[17.]
B.K. De, S. Sen, P.K. Biswas.
Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression.
Gastroenterology, 122 (2002), pp. 897-903
Copyright © 2008. Revista Colombiana de Anestesiología
Download PDF
Article options